Malware
BloodAlchemy
- First Reported
- Aug 19, 2026
- Latest Reported
- Nov 20, 2026
Reported Context (8)
- BLOODALCHEMY was reported within the wider VAPOR PANDA campaign; its use should not be assumed for each pharmaceutical victim. CYFIRMA Report Maps Pharmaceutical Cyber Threats in 2026
- 6. Exploitation and Persistence Artifacts: Web shells; evidence of BLOODALCHEMY components; open- FBI Warns ARTEX Framework Is Enabling Faster, Larger-Scale Intrusions
- CrowdStrike confirmed post-exploitation at nine victims, documenting the BLOODALCHEMY backdoor at a Middle East interior ministry and a Latin American foreign ministry, and password spraying or credential scanning ARTEX AI Framework Linked to Multiple 2026 Intrusion Campaigns
- CrowdStrike also found that the threat actor deployed BLOODALCHEMY, a backdoor active since 2023, against government entities in Latin America and the Middle East. Vapor Panda Used ARTEX AI in Attacks Targeting More Than 200 Organizations
- Post-exploitation activity has been confirmed at nine organizations, allowing the attacker to deploy BLOODALCHEMY, a derivative of ShadowPad, followed by credential spraying, network scanning, and reconnaissance. CrowdStrike Says Vapor Panda Used AI-Powered ARTEX Against 200+ Organizations
CVE (2)
Malware (14)
People (4)
Threat Actors (28)
MITRE ATT&CK (43)
Vendors (7)
Products (18)
Tools (13)
Industries (17)
Countries (25)
Note: Related entities, including threat actors, malware, CVEs, MITRE ATT&CK techniques, vendors, products, tools, countries, and industries, are shown when they appear in the same reporting. Their presence does not necessarily mean they were targeted, compromised, vulnerable, responsible for the activity, or directly involved in the incident.
